Cognition Therapeutics, Inc. is a clinical-stage neuroscience company developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders.

Biotechnology

Education

CogRx

CogRx's headquarters in Harrison, NY, United States

Lisa Ricciardi

Gilbert M. Rishton

John Doyle

Anthony Caggiano

Anthony O. Caggiano

Michael Grundman

Kaj Blennow

Steven DeKosky

Rolf Craven

John Harrison

John Cirrito

Tara L. Spires-Jones

Robert H. Mach

Peggy Wallace

Cynthia A. Lemere

Philip Scheltens

Aaron Fletcher

Jack A. Khattar

Brett P. Monia

Mary Sano

Larry Ereshefsky

Alison M. Goate

Henrik Zetterberg

Michael Cahill

Harry LeVine III

Ellen B. Richstone

The Scientific Advisors team at CogRx plays a critical role in guiding the company's research and development efforts by providing expert insights on neurodegenerative and neuro-ophthalmic disorders. They collaborate with cross-functional teams to design clinical trials, interpret scientific data, and ensure that the company's therapeutic strategies align with the latest advancements in neuroscience. Their expertise helps inform decision-making and drive the development of innovative treatments.

Scientific Advisors

The Clinical Operations team at CogRx is responsible for overseeing the planning, implementation, and management of clinical trials for neurodegenerative and neuro-ophthalmic drug candidates. This team ensures compliance with regulatory standards, coordinates between cross-functional departments, and drives project timelines to facilitate the development of innovative therapies aimed at restoring cellular function in affected disorders.

Clinical Operations

The Research and Development Team at CogRx is dedicated to advancing the company’s mission by conducting innovative scientific research and clinical trials focused on neurodegenerative and neuro-ophthalmic disorders. This team collaborates to discover, develop, and optimize therapeutic candidates, utilizing their expertise in neuroscience and chemistry to restore normal cellular responses and improve treatment outcomes for patients. Their work involves experimental design, data analysis, and translating research findings into potential drug candidates.

Research and Development Team

This department encompasses the strategic oversight and direction of the organization.

Executive Leadership

The Finance Team at CogRx is responsible for managing the company's financial health, including budgeting, forecasting, and financial reporting. They analyze financial data to support strategic decision-making, ensure compliance with regulatory requirements, and optimize resource allocation to facilitate the development of innovative therapies for neurodegenerative disorders.

Finance Team

The Leadership Team at CogRx is responsible for setting the strategic vision and direction for the company, overseeing clinical development and research initiatives, and ensuring the alignment of scientific goals with business objectives. They collaborate to drive innovation in neurodegenerative and neuro-ophthalmic disorder therapies, while also fostering a culture of excellence and accountability across all levels of the organization.

Leadership Team

CogRx

Org chart

Board & advisors

Teams

Scientific Advisors

Clinical Operations

Research and Development Team

Executive Leadership

Finance Team

Leadership Team

Offices

CogRx

Org chart

Board & advisors

Teams

Scientific Advisors

Clinical Operations

Research and Development Team

Executive Leadership

Finance Team

Leadership Team

Offices

Related companies